BE652807A - - Google Patents

Info

Publication number
BE652807A
BE652807A BE652807DA BE652807A BE 652807 A BE652807 A BE 652807A BE 652807D A BE652807D A BE 652807DA BE 652807 A BE652807 A BE 652807A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE652807A publication Critical patent/BE652807A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE652807D 1963-09-10 1964-09-08 BE652807A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1115563 1963-09-10

Publications (1)

Publication Number Publication Date
BE652807A true BE652807A (fr) 1965-03-08

Family

ID=4370622

Family Applications (1)

Application Number Title Priority Date Filing Date
BE652807D BE652807A (fr) 1963-09-10 1964-09-08

Country Status (10)

Country Link
US (1) US3431338A (fr)
BE (1) BE652807A (fr)
BR (1) BR6462426D0 (fr)
DE (1) DE1204363B (fr)
DK (1) DK112191B (fr)
ES (1) ES303909A1 (fr)
FR (1) FR4213M (fr)
GB (1) GB1017674A (fr)
IL (1) IL21981A (fr)
NL (1) NL6410434A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040590A2 (fr) * 1980-05-21 1981-11-25 Aktiebolaget Hässle Préparation pharmaceutique à propriétés de libération améliorées
EP0366621A1 (fr) * 1988-10-20 1990-05-02 BOEHRINGER INGELHEIM ITALIA S.p.A. Préparations pharmaceutiques orales à délivrance sélective dans le colon

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1115596B (it) * 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (fr) * 1980-03-20 1982-03-11
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
US4965089A (en) * 1989-04-10 1990-10-23 Sauter Manufacturing Corp. Method and apparatus for the gelatin coating of caplets
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
CN1072964C (zh) 1994-04-22 2001-10-17 山之内制药株式会社 结肠特异性释药系统
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CA2607949C (fr) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Bifidobacteries de probiotiques felins
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2013035081A2 (fr) 2011-09-07 2013-03-14 JÄNISCH, Melisa Formulation optimale pour la libération d'un principe actif dans le gros intestin
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957804A (en) * 1958-06-06 1960-10-25 Harlan R Shuyler Pesticide

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040590A2 (fr) * 1980-05-21 1981-11-25 Aktiebolaget Hässle Préparation pharmaceutique à propriétés de libération améliorées
EP0040590A3 (fr) * 1980-05-21 1983-01-12 Aktiebolaget Hässle Préparation pharmaceutique à propriétés de libération améliorées
EP0366621A1 (fr) * 1988-10-20 1990-05-02 BOEHRINGER INGELHEIM ITALIA S.p.A. Préparations pharmaceutiques orales à délivrance sélective dans le colon
WO1990004386A1 (fr) * 1988-10-20 1990-05-03 Istituto De Angeli S.P.A. Preparations pharmaceutiques orales a acheminement selectif au colon

Also Published As

Publication number Publication date
ES303909A1 (es) 1965-07-16
GB1017674A (en) 1966-01-19
IL21981A (en) 1968-02-26
DE1204363B (de) 1965-11-04
BR6462426D0 (pt) 1973-08-07
US3431338A (en) 1969-03-04
FR4213M (fr) 1966-06-13
DK112191B (da) 1968-11-18
NL6410434A (fr) 1965-03-11

Similar Documents

Publication Publication Date Title
AR142945A1 (fr)
AT260747B (fr)
BE645507A (fr)
BE624811A (fr)
BE623220A (fr)
BE626938A (fr)
BE645827A (fr)
BE645597A (fr)
BE31062A (fr)
BE462764A (fr)
BE465565A (fr)
BE507458A (fr)
BE533484A (fr)
BE547422A (fr)
BE582314A (fr)
BE645297A (fr)
BE603935A (fr)
BE644877A (fr)
BE608372A (fr)
BE644798A (fr)
BE643696A (fr)
BE612803A (fr)
BE614220A (fr)
BE616247A (fr)
BE616830A (fr)